AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
July 25, 2018

Obesity and how it affects GI patients

Insights on how to define new treatment options, refine existing approaches and identify areas of need in obesity research.

Share on facebook
Share on twitter
Share on linkedin
Share on email

Treating obesity is critical to providing optimal treatment for GI-related diseases. Understanding the cause of obesity means examining factors that contribute to a patient’s metabolic response to a meal, including how nutrients/food interact with the gut microbiome, peripheral organs and other metabolic pathways.

In addition, genetics, the environment and psychosocial interactions significantly influence the mechanisms that govern the regulatory pathways of energy intake and expenditure. 

By attending the James W. Freston Conference on Obesity and Metabolic Disease, you will: 

    • Gain a deeper understanding of the options available to treat obesity in pediatrics and adults.
    • Get a broader understanding of the endoscopic and surgical treatments currently available and those to come.
    • Discover how to incorporate obesity care and intervention into clinical practice. 

Learn more and join fellow clinicians and researchers for the James W. Freston Conference on Obesity and Metabolic Disease, this Aug. 18 & 19 in Arlington, Virginia. Register today, visit http://freston.gastro.org. Be sure to reserve your hotel room by July 27 to receive the discounted rate. Online registration ends Aug. 6. 

Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.